Abstract
Western blotting has been widely utilized to detect various polypeptides or polypeptide epitopes (e.g., posttranslational modifications) within cells (reviewed in 1-4). If the signals in samples being analyzed are compared to a suitable standard curve and appropriate internal standards are utilized to confirm equivalent loading of various samples, Western blotting appears to be a suitable method of quantitating polypeptides as well.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Gershoni, J. M. and Palade, G. E. (1983) Protein blotting: principles and applications. Anal. Biochem. 131, 1–15.
Beisiegel, U. (1986) Protein blotting. Electrophoresis 7, 1–18.
Stott, D. I. (1989) Immunoblotting and dot blotting. J. Immunol. Methods 119, 153–187.
Kaufmann, S. H. and Kellner, U. (1998) Erasure of Western blots after autoradiography or chemiluminescent detection, in Methods in Molecular Biology, vol. 80 (Pound, J., ed.), Humana Press, Totowa, NJ, pp. 223–236.
Chen, A. Y. and Liu, L. F. (1994) DNA Topoisomerases: essential enzymes and lethal targets. Ann. Rev. Pharmacol. Toxicol. 34, 191–218.
Pommier, Y., Leteurtre, F., Fesen, M. R., Fujimori, A., Bertrand, R., Solary, E., Kohlhagen, G., and Kohn, K. W. (1994) Cellular determinants of sensitivity and resistance to DNA topoisomerase inhibitors. Cancer Invest. 12, 530–542.
Froelich-Ammon, S. J. and Osheroff, N. (1995) Topoisomerase poisons: harnessing the dark side of enzyme mechanism. J. Biol. Chem. 270, 21,429–21,432.
Tricoli, J. V. and Kowalski, D. (1983) Topoisomerase I from chicken erythrocytes: purification, characterization, and detection by a deoxyribonucleic acid binding assay. Biochemistry 22, 2025–2031.
Hsiang, Y.-H. and Liu, L. F. (1988) Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancer drug camptothecin. Cancer Res. 48, 1722–1726.
Zwelling, L. A., Hinds, M., Chan, D., Mayes, J., Sie, K. L., Parker, E., Silberman, L., Radcliffe, A., Beran, M., and Blick, M. (1989) Characterization of an amsacrine-resistant line of human leukemia cells. Evidence for a drug-resistant form of topoisomerase II. J. Biol. Chem. 264, 16,411–16,420.
Hendricks, C. B., Rowinsky, E. K., Grochow, L. B., Donehower, R. C., and Kaufmann, S. H. (1992) Effect of P-glycoprotein expression on the accumulation and cytotoxicity of topotecan (SK&F 104864), a new camptothecin analogue. Cancer Res. 52, 2268–2278.
Kaufmann, S. H., Desnoyers, S., Ottaviano, Y., Davidson, N., and Poirier, G. G. (1993) Specific proteolytic fragmentation of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res. 53, 3976–3985.
McGahon, A., Bissonnette, R., Schmitt, M., Cotter, K. M., Green, D. R., and Cotter, T. G. (1994) BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death. Blood 83, 1179–1187.
Kaufmann, S. H., McLaughlin, S. J., Kastan, M., Liu, L. F., Karp, J. E., and Burke, P. J. (1991) Topoisomerase II levels during granulocytic maturation in vitro and in vivo. Cancer Res. 51, 3534–3543.
James, G. T. (1978) Inactivation of the protease inhibitor phenylmethylsulfonyl fluoride in buffers. Anal. Biochem. 86, 574–579.
English, D. and Andersen, B. R. (1974) Single-step separation of red blood cells. Granulocytes and mononuclear leukocytes on discontinuous density gradients of Ficoll-hypaque. J. Immunol. Methods 5, 249–252.
Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K., Gartner, F. H., Provenzano, M. D., Fujimoto, E. K., Goeke, N. M., Olson, B. J., and Klenk, D. C. (1985) Measurement of protein using bicinchoninic acid. Anal. Biochem. 150, 76–85.
Laemmli, U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680–685.
Parekh, B. S., Mehta, H. B., West, M. D., and Montelaro, R. C. (1985) Preparative elution of proteins from nitrocellulose membranes after separation by sodium dodecylsulfate-polyacrylamide gel electrophoresis. Anal. Biochem. 148, 87–92.
Salinovich, O. and Montelaro, R. C. (1986) Reversible staining and peptide mapping of proteins transferred to nitrocellulose after separation by sodium dodceylsulfate-polyacrylamide gel electrophoresis. Anal. Biochem. 156, 341–347.
Kaufmann, S. H. (1991) Antagonism between camptothecin and topoisomerase II-directed chemotherapeutic agents in a human leukemia cell line. Cancer Res. 51, 1129–1136.
Kaufmann, S. H. (1989) Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note. Cancer Res. 49, 5870–5878.
Tanizawa, A., Fujimori, A., Fujimori, Y., and Pommier, Y. (1994) Comparison of topoisomerase I inhibition, DNA damage, and cytotoxicity of camptothecin derivatives presently in clinical trials. J. Natl. Cancer Inst. 86, 836–842.
Heck, M. M., Hittelman, W. N., and Earnshaw, W. C. (1988) Differential expression of DNA topoisomerase I and II during the eukaryotic cell cycle. Proc. Natl. Acad. Sci. USA 85, 1086–1090.
Amrein, P. C. and Stossel, T. P. (1980) Prevention of degradation of human polymorphonuclear leukocyte proteins by diisopropylfluorophosphate. Blood 56, 442–447.
Fish, W. W., Reynolds, J. A., and Tanford, C. (1970) Gel chromatography of proteins in denaturing solvents. Comparison between sodium dodecyl sulfate and guanidine hydrochloride as denaturants. J. Biol. Chem. 245, 5166–5168.
Kaufmann, S. H., Karp, J. E., Jones, R. J., Miller, C. B., Schneider, E., Zwelling, L. A., Cowan, K., Wendel, K., and Burke, P. J. (1994) Topoisomerase II levels and drug sensitivity in adult acute myelogenous leukemia. Blood 83, 517–530.
Pampori, N. A., Pampori, M. K., and Shapiro, B. H. (1995) Dilution of the chemiluminescence reagents reduces the background noise on western blots. Biotechniques 18, 588–590.
Shea, T. B. (1994) Technical report. An inexpensive densitometric analysis system using a Macintosh computer and a desktop scanner. Biotechniques 16, 1126–1128.
Hsiang, Y. H. and Liu, L. F. (1989) Evidence for the reversibility of cellular DNA lesion induced by mammalian topoisomerase II poisons. J. Biol. Chem. 264, 9713–9715.
Kaufmann, S. H., Svingen, P. A., Gore, S. D., Armstrong, D. K., Cheng, Y-C., and Rowinsky, E. K. (1997) Altered formation of topotecan-stabilized topoisomerase I-DNA adducts in human leukemia cells. Blood 89, 2098–2104.
Slichenmyer, W. J., Rowinsky, E. K., Donehower, R. C., and Kaufmann, S. H. (1993) The current status of camptothecin analogues as antitumor agents. J. Natl. Cancer Inst. 85, 271–291.
Kaufmann, S. H., Charron, M., Burke, P. J., and Karp, J. E. (1995) Changes in topoisomerase I levels and subnuclear localization during myeloid maturation in vitro and in vivo. Cancer Res. 55, 1255–1260.
Desnoyers, S., Kaufmann, S. H., and Poirier, G. G. (1996) Alteration of the nucleolar localization of poly(ADP-ribose) polymerase upon treatment with transcription inhibitors. Exp. Cell Res. 227, 146–153.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Humana Press Inc.
About this protocol
Cite this protocol
Kaufmann, S.H., Svingen, P.A. (1999). Immunoblot Analysis and Band Depletion Assays. In: Bjornsti, MA., Osheroff, N. (eds) DNA Topoisomerase Protocols. Methods in Molecular Biology, vol 94. Humana, Totowa, NJ. https://doi.org/10.1385/1-59259-259-7:253
Download citation
DOI: https://doi.org/10.1385/1-59259-259-7:253
Published:
Publisher Name: Humana, Totowa, NJ
Print ISBN: 978-0-89603-444-0
Online ISBN: 978-1-59259-259-3
eBook Packages: Springer Protocols